The market's been on a bull run, but most of the gains have been confined to a handful of tech stocks at the top. There are still plenty of high-yield dividend stocks that haven't gained as much attention as they probably deserve. Investors looking for near-certain ways to grow the stream of passive income their retirement accounts produce have some terrific options. Medtronic(NYSE: MDT), Agree Realty(NYSE: ADC), and Realty Income(NYSE: O) offer an average yield of about 4.7% at recent prices. Here's how these well-established dividend payers could continue meeting and raising their dividend commitments in the decade ahead. Medtronic Medtronic is the world's largest developer and manufacturer of innovative medical devices. At recent prices, the stock offers a 3.6% dividend yield that investors can reasonably expect to rise in the decade ahead. In May, the company raised its dividend payout for the 47th consecutive year. With Medtronic's long history of developing and marketing new devices, its sales representatives find it relatively easy to engage with busy hospital purchasing managers. That makes investing in new technologies significantly less risky than it is for its competitors. The 2018 acquisition of Mazor Robotics for $1.6 billion is a prime example of Medtronic's size advantage. Mazor's spine and brain surgical guidance systems for minimally invasive procedures support a neuroscience portfolio that generated $9.4 billion in revenue during fiscal 2024, a 5% year-over-year increase. In April, the company received FDA approval for a new spinal cord stimulator that could help its neuroscience segment continue growing. Since this is a well-established medtech giant, rapid growth isn't likely. But steady gains for at least another decade aren't an unreasonable expectation. Agree Realty Agree Realty is a real estate investment trust (REIT), which means it can legally avoid income taxes by distributing nearly all it earns to shareholders as dividend payments. At recent prices, it offers a 4.7% yield and a great chance to see the payout expand. In 2021, Agree Realty switched from quarterly to monthly dividend payments. On an annual basis, though, its dividend has risen steadily since 2011. Agree Realty employs long-term net leases that make tenants responsible for all the variable costs of building ownership, such as taxes and building maintenance. More than half of the rent the company expects to receive annually comes from leases that mature after 2030 or later. With annual rent escalators written into long-term net leases, Agree Realty has highly predictable cash flows. Investors can look forward to significant payout bumps in the quarters ahead. Agree Realty expects adjusted funds from operations (FFO), a proxy for earnings used to evaluate REITs, to land in a range between $4.10 and $4.13 per share this year. That gives management plenty of room to raise the payout from its present level of $3.00 per share annually. Realty Income Realty Income is another net-lease REIT that focuses on commercial properties that aren't very susceptible to e-commerce, such as grocery stores, convenience stores, and dollar stores. Maintaining a diverse portfolio has allowed it to raise its dividend payout every quarter since becoming a publicly traded company in 1994. At recent prices, Realty Income shares offer an eye-popping 5.7% dividend yield. With 15,485 commercial properties already in its portfolio at the end of March, though, rapid growth in the years ahead doesn't seem likely. You probably shouldn't buy Realty Income expecting dramatic dividend growth, but this stock can help you become rich over time. The REIT finished March with about $4 billion in available liquidity and an A3 credit rating from Moody's. That means it has the necessary resources to continue consolidating a European commercial real estate market with relatively few competitors. Realty Income's dividend growth rate in the decade ahead might not be as fast as it's been. With a fractured global market for commercial real estate and plenty of liquidity, though, investors can reasonably rely on continued payout raises throughout the decade ahead. Should you invest $1,000 in Medtronic right now? Before you buy stock in Medtronic, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Medtronic wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $791,929!* Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. TheStock Advisorservice has more than quadrupled the return of S&P 500 since 2002*. See the 10 stocks » *Stock Advisor returns as of July 8, 2024 Cory Renauer has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Moody's and Realty Income. The Motley Fool recommends Medtronic and recommends the following options: long January 2026 $75 calls on Medtronic and short January 2026 $85 calls on Medtronic. The Motley Fool has a disclosure policy. 3 High-Yield Dividend Stocks to Buy in the 2nd Half of 2024 and Hold at Least a Decade was originally published by The Motley Fool
3 High-Yield Dividend Stocks to Buy in the 2nd Half of 2024 and Hold at Least a Decade
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...